Coronavirus Disease 2019 (COVID-19)
Coronavirus disease (COVID-19) is a new strain that was discovered in 2019 and has not been previously identified in humans.
Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, the infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.
Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.
Clinical Videos for Healthcare Providers
The predominant COVID‐19 illness is a viral pneumonia. Airway interventions are mainly required for tracheal intubation and establishing controlled ventilation. This consensus statement has been brought together at short notice to advise on airway management for patients with COVID‐19, drawing on published literature and immediately available information from clinicians and experts.
This overview analyzes the best information from the early research on the novel coronavirus, COVID-19, and offers valuable links to the most reliable and trustworthy resources to stay up-to-date.
Approximately 17% of confirmed cases of COVID-19 develop severe disease with acute respiratory distress syndrome (ARDS). Like other patient groups with ARDS, patients with severe COVID-19 are likely to be considered for emergency tracheal intubation and mechanical ventilation to support potential recovery from their illness.
The Surviving Sepsis Campaign COVID-19 panel issued 54 statements, of which 4 are best practice statements, 9 are strong recommendations, and 35 are weak recommendations. No recommendation was provided for 6 questions. The topics were: 1) infection control, 2) laboratory diagnosis and specimens, 3) hemodynamic support, 4) ventilatory support, and 5) COVID-19 therapy.